Figure 4.
Survival analysis according to short vs long DTI in all subtype groups. Kaplan-Meier curves of EFS (A,C,E) and OS (B,D,F) in patients with a DTI of <15 days vs ≥15 days for all study-eligible patients with aggressive HIV-NHL (n = 86) (A-B)B); all DLBCL (n = 61) (C-D); non-GCB (n = 26) (E-F); and GGB (n = 34) (G-H) DLBCL subtypes (1 case was not classified).